$NAVB Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in NAVIDEA BIOPHARMACEUTICALS, INC..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in NAVIDEA BIOPHARMACEUTICALS, INC.. Get notifications about new insider transactions in NAVIDEA BIOPHARMACEUTICALS, INC. for free.

Page: 1 2 3 4 5 ... 5 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
May 06 2021	NAVB	NAVIDEA BIOPHARMAC ...	Bhalla Amit	Director	Option Exercise	A	1.64	2,500	4,100	2,500
May 06 2021	NAVB	NAVIDEA BIOPHARMAC ...	Bhalla Amit	Director	Grant	A	0.00	2,500	3	2,500	0 to 2.5 K
Apr 26 2021	NAVB	NAVIDEA BIOPHARMAC ...	Witter Malcolm G	Director	Buy	P	1.60	10,000	16,000	57,000	47 K to 57 K (+21.28 %)
Mar 29 2021	NAVB	NAVIDEA BIOPHARMAC ...	Witter Malcolm G	Director	Buy	P	2.07	21,500	44,505	47,000	25.5 K to 47 K (+84.31 %)
Mar 04 2021	NAVB	NAVIDEA BIOPHARMAC ...	Scott John K Jr.	10% Owner	Option Exercise	P	2.30	50,000	115,000	50,000
Mar 03 2021	NAVB	NAVIDEA BIOPHARMAC ...	Witter Malcolm G	Director	Buy	P	2.31	15,000	34,650	25,500	10.5 K to 25.5 K (+142.86 %)
Feb 17 2021	NAVB	NAVIDEA BIOPHARMAC ...	Rosol Michael Stanley	Chief Medical Offic ...	Option Exercise	A	2.56	25,000	64,000	25,000
Feb 17 2021	NAVB	NAVIDEA BIOPHARMAC ...	Latkin Jed	CEO, COO & CFO	Option Exercise	A	2.56	100,000	256,000	100,000
Jan 14 2021	NAVB	NAVIDEA BIOPHARMAC ...	Witter Malcolm G	Director	Option Exercise	A	2.28	2,500	5,700	2,500
Jan 14 2021	NAVB	NAVIDEA BIOPHARMAC ...	Witter Malcolm G	Director	Grant	A	0.00	2,500	3	13,000	10.5 K to 13 K (+23.81 %)
Jan 14 2021	NAVB	NAVIDEA BIOPHARMAC ...	Rouan Sarah Kathryn	Director	Option Exercise	A	2.28	2,500	5,700	2,500
Jan 14 2021	NAVB	NAVIDEA BIOPHARMAC ...	Rouan Sarah Kathryn	Director	Grant	A	0.00	2,500	3	13,350	10.9 K to 13.4 K (+23.04 %)
Jan 14 2021	NAVB	NAVIDEA BIOPHARMAC ...	RICE YEHUDA MICHAEL	Director	Option Exercise	A	2.28	2,500	5,700	2,500
Jan 14 2021	NAVB	NAVIDEA BIOPHARMAC ...	RICE YEHUDA MICHAEL	Director	Grant	A	0.00	2,500	3	12,500	10 K to 12.5 K (+25.00 %)
Jan 14 2021	NAVB	NAVIDEA BIOPHARMAC ...	Cutler Adam D.	Director	Option Exercise	A	2.28	2,500	5,700	2,500
Jan 14 2021	NAVB	NAVIDEA BIOPHARMAC ...	Cutler Adam D.	Director	Grant	A	0.00	2,500	3	10,000	7.5 K to 10 K (+33.33 %)
Jan 14 2021	NAVB	NAVIDEA BIOPHARMAC ...	Bruck Claudine	Director	Option Exercise	A	2.28	2,500	5,700	2,500
Jan 14 2021	NAVB	NAVIDEA BIOPHARMAC ...	Bruck Claudine	Director	Grant	A	0.00	2,500	3	12,550	10.1 K to 12.6 K (+24.88 %)
Dec 30 2020	NAVB	NAVIDEA BIOPHARMAC ...	Witter Malcolm G	Director	Buy	P	2.07	5,000	10,350	10,500	5.5 K to 10.5 K (+90.91 %)
Nov 06 2020	NAVB	NAVIDEA BIOPHARMAC ...	Kaufman Joel H.	Chief Business Offi ...	Option Exercise	A	2.31	20,000	46,200	20,000
Sep 02 2020	NAVB	NAVIDEA BIOPHARMAC ...	Scott John K Jr.	10% Owner	Buy	P	5.00	5,000	25,000	8,047,162	8 M to 8 M (+0.06 %)
Sep 02 2020	NAVB	NAVIDEA BIOPHARMAC ...	Scott John K Jr.	10% Owner	Buy	P	5.00	5,000	25,000	8,047,162	8 M to 8 M (+0.06 %)
Aug 18 2020	NAVB	NAVIDEA BIOPHARMAC ...	Latkin Jed	CEO, COO & CFO	Option Exercise	A	4.70	100,000	470,000	100,000
Aug 18 2020	NAVB	NAVIDEA BIOPHARMAC ...	Latkin Jed	CEO, COO & CFO	Grant	A	0.00	50,000	50	107,997	58 K to 108 K (+86.21 %)
Jun 04 2020	NAVB	NAVIDEA BIOPHARMAC ...	Rosol Michael Stanley	Chief Medical Offic ...	Grant	A	2.62	6,847	17,939	13,097	6.3 K to 13.1 K (+109.55 %)
Jun 04 2020	NAVB	NAVIDEA BIOPHARMAC ...	Latkin Jed	CEO, COO & CFO	Grant	A	2.62	33,997	89,072	57,997	24 K to 58 K (+141.65 %)
Feb 20 2020	NAVB	NAVIDEA BIOPHARMAC ...	Latkin Jed	CEO, COO & CFO	Buy	P	1.08	5,000	5,400	17,950	13 K to 18 K (+38.61 %)
Feb 19 2020	NAVB	NAVIDEA BIOPHARMAC ...	Scott John K Jr.	10% Owner	Buy	P	0.85	2,373,529	2,017,500	8,042,162	5.7 M to 8 M (+41.87 %)
Feb 07 2020	NAVB	NAVIDEA BIOPHARMAC ...	Rosol Michael Stanley	Chief Medical Offic ...	Option Exercise	A	1.06	25,000	26,500	31,250
Feb 07 2020	NAVB	NAVIDEA BIOPHARMAC ...	Rouan Sarah Kathryn	Director	Option Exercise	A	1.06	2,500	2,650	7,500
Feb 07 2020	NAVB	NAVIDEA BIOPHARMAC ...	Rouan Sarah Kathryn	Director	Grant	A	0.00	2,500	3	10,850	8.4 K to 10.9 K (+29.94 %)
Feb 07 2020	NAVB	NAVIDEA BIOPHARMAC ...	RICE YEHUDA MICHAEL	Director	Option Exercise	A	1.06	2,500	2,650	10,000
Feb 07 2020	NAVB	NAVIDEA BIOPHARMAC ...	RICE YEHUDA MICHAEL	Director	Grant	A	0.00	2,500	3	10,000	7.5 K to 10 K (+33.33 %)
Feb 07 2020	NAVB	NAVIDEA BIOPHARMAC ...	Cutler Adam D.	Director	Option Exercise	A	1.06	2,500	2,650	7,500
Feb 07 2020	NAVB	NAVIDEA BIOPHARMAC ...	Cutler Adam D.	Director	Grant	A	0.00	2,500	3	7,500	5 K to 7.5 K (+50.00 %)
Dec 11 2019	NAVB	NAVIDEA BIOPHARMAC ...	Scott John K Jr.	10% Owner	Buy	P	0.90	555,555	500,000	5,668,633	5.1 M to 5.7 M (+10.87 %)
Jun 21 2019	NAVB	NAVIDEA BIOPHARMAC ...	Scott John K Jr.	10% Owner	Buy	P	0.75	4,000,000	3,000,000	5,113,078	1.1 M to 5.1 M (+359.36 %)
Jun 21 2019	NAVB	NAVIDEA BIOPHARMAC ...	Scott John K Jr.	10% Owner	Buy	P	0.75	4,000,000	3,000,000	5,113,078	1.1 M to 5.1 M (+359.36 %)
Jun 07 2019	NAVB	NAVIDEA BIOPHARMAC ...	Latkin Jed	CEO, COO & CFO	Buy	P	1.26	1,000	1,258	12,950	12 K to 13 K (+8.37 %)
May 21 2019	NAVB	NAVIDEA BIOPHARMAC ...	Rouan Sarah Kathryn	Director	Buy	P	1.46	3,350	4,904	8,350	5 K to 8.4 K (+67.00 %)
May 17 2019	NAVB	NAVIDEA BIOPHARMAC ...	Latkin Jed	CEO, COO & CFO	Buy	P	1.46	1,000	1,463	11,950	11 K to 12 K (+9.13 %)
May 17 2019	NAVB	NAVIDEA BIOPHARMAC ...	Latkin Jed	CEO, COO & CFO	Buy	P	1.45	1,500	2,180	10,950	9.5 K to 11 K (+15.87 %)
May 15 2019	NAVB	NAVIDEA BIOPHARMAC ...	Bruck Claudine	Director	Buy	P	1.90	2,550	4,855	7,550	5 K to 7.6 K (+51.00 %)
May 15 2019	NAVB	NAVIDEA BIOPHARMAC ...	Latkin Jed	CEO, COO & CFO	Buy	P	1.45	1,000	1,448	9,450	8.5 K to 9.5 K (+11.83 %)
May 15 2019	NAVB	NAVIDEA BIOPHARMAC ...	Latkin Jed	CEO, COO & CFO	Buy	P	1.84	2,000	3,679	8,450	6.5 K to 8.5 K (+31.01 %)
May 15 2019	NAVB	NAVIDEA BIOPHARMAC ...	Latkin Jed	CEO, COO & CFO	Buy	P	1.91	2,400	4,595	6,450	4.1 K to 6.5 K (+59.26 %)
Mar 25 2019	NAVB	NAVIDEA BIOPHARMAC ...	Scott John K Jr.	10% Owner	Buy	P	0.14	357,143	50,000	22,261,565	21.9 M to 22.3 M (+1.63 %)
Feb 12 2019	NAVB	NAVIDEA BIOPHARMAC ...	RICE YEHUDA MICHAEL	Director	Option Exercise	A	0.25	50,000	12,500	150,000
Feb 12 2019	NAVB	NAVIDEA BIOPHARMAC ...	RICE YEHUDA MICHAEL	Director	Grant	A	0.00	50,000	50	150,000	100 K to 150 K (+50.00 %)
Feb 12 2019	NAVB	NAVIDEA BIOPHARMAC ...	Rouan Sarah Kathryn	Director	Option Exercise	A	0.25	50,000	12,500	100,000
Feb 12 2019	NAVB	NAVIDEA BIOPHARMAC ...	Rouan Sarah Kathryn	Director	Grant	A	0.00	50,000	50	100,000	50 K to 100 K (+100.00 %)
Feb 12 2019	NAVB	NAVIDEA BIOPHARMAC ...	Cutler Adam D.	Director	Option Exercise	A	0.25	50,000	12,500	100,000
Feb 12 2019	NAVB	NAVIDEA BIOPHARMAC ...	Cutler Adam D.	Director	Grant	A	0.00	50,000	50	100,000	50 K to 100 K (+100.00 %)
Feb 12 2019	NAVB	NAVIDEA BIOPHARMAC ...	Bruck Claudine	Director	Option Exercise	A	0.25	50,000	12,500	100,000
Feb 12 2019	NAVB	NAVIDEA BIOPHARMAC ...	Bruck Claudine	Director	Grant	A	0.00	50,000	50	100,000	50 K to 100 K (+100.00 %)
Feb 11 2019	NAVB	NAVIDEA BIOPHARMAC ...	Latkin Jed	CEO, COO & CFO	Option Exercise	A	0.00	1,000,000	0	2,065,000
Jan 03 2019	NAVB	NAVIDEA BIOPHARMAC ...	Rouan Sarah Kathryn	Director	Option Exercise	A	0.75	50,000	37,500	50,000
Jan 03 2019	NAVB	NAVIDEA BIOPHARMAC ...	Rouan Sarah Kathryn	Director	Grant	A	0.00	50,000	50	50,000	0 to 50 K
Jan 03 2019	NAVB	NAVIDEA BIOPHARMAC ...	Cutler Adam D.	Director	Option Exercise	A	0.75	50,000	37,500	50,000
Jan 03 2019	NAVB	NAVIDEA BIOPHARMAC ...	Cutler Adam D.	Director	Grant	A	0.00	50,000	50	50,000	0 to 50 K
Jul 13 2018	NAVB	NAVIDEA BIOPHARMAC ...	Cope Frederick O	SVP & CSO	Grant	A	0.23	212,390	48,850	585,052	372.7 K to 585.1 K (+56.99 %)
Mar 16 2018	NAVB	NAVIDEA BIOPHARMAC ...	Bruck Claudine	Director	Option Exercise	A	0.75	50,000	37,500	50,000
Mar 16 2018	NAVB	NAVIDEA BIOPHARMAC ...	Bruck Claudine	Director	Grant	A	0.00	50,000	50	50,000	0 to 50 K
Feb 22 2018	NAVB	NAVIDEA BIOPHARMAC ...	Rowinsky Eric K	Director	Option Exercise	A	0.75	50,000	37,500	173,764
Feb 22 2018	NAVB	NAVIDEA BIOPHARMAC ...	Rowinsky Eric K	Director	Grant	A	0.00	50,000	50	341,446	291.4 K to 341.4 K (+17.16 %)
Feb 22 2018	NAVB	NAVIDEA BIOPHARMAC ...	RICE YEHUDA MICHAEL	Director	Option Exercise	A	0.75	50,000	37,500	100,000
Feb 22 2018	NAVB	NAVIDEA BIOPHARMAC ...	RICE YEHUDA MICHAEL	Director	Grant	A	0.00	50,000	50	100,000	50 K to 100 K (+100.00 %)
Feb 22 2018	NAVB	NAVIDEA BIOPHARMAC ...	Greene Mark I	Director	Option Exercise	A	0.75	50,000	37,500	100,000
Feb 22 2018	NAVB	NAVIDEA BIOPHARMAC ...	Greene Mark I	Director	Grant	A	0.00	50,000	50	157,244	107.2 K to 157.2 K (+46.62 %)
Feb 22 2018	NAVB	NAVIDEA BIOPHARMAC ...	Cope Frederick O	SVP & CSO	Grant	A	0.36	135,694	48,850	372,662	237 K to 372.7 K (+57.26 %)
Sep 19 2017	NAVB	NAVIDEA BIOPHARMAC ...	RICE YEHUDA MICHAEL	Director	Gift	G	0.00	28,000	0	50,000	78 K to 50 K (-35.90 %)
Jul 03 2017	NAVB	NAVIDEA BIOPHARMAC ...	Regan William J.	SVP & CCO	Buy	P	0.53	20,000	10,586	172,977	153 K to 173 K (+13.07 %)
Jun 30 2017	NAVB	NAVIDEA BIOPHARMAC ...	Rowinsky Eric K	Director	Option Exercise	A	0.75	50,000	37,500	50,000
Jun 30 2017	NAVB	NAVIDEA BIOPHARMAC ...	Rowinsky Eric K	Director	Grant	A	0.00	50,000	50	291,446	241.4 K to 291.4 K (+20.71 %)
Jun 30 2017	NAVB	NAVIDEA BIOPHARMAC ...	RICE YEHUDA MICHAEL	Director	Option Exercise	A	0.75	50,000	37,500	50,000
Jun 30 2017	NAVB	NAVIDEA BIOPHARMAC ...	RICE YEHUDA MICHAEL	Director	Grant	A	0.00	50,000	50	78,000	28 K to 78 K (+178.57 %)
Jun 30 2017	NAVB	NAVIDEA BIOPHARMAC ...	Greene Mark I	Director	Option Exercise	A	0.75	50,000	37,500	50,000
Jun 30 2017	NAVB	NAVIDEA BIOPHARMAC ...	Greene Mark I	Director	Grant	A	0.00	50,000	50	107,244	57.2 K to 107.2 K (+87.35 %)
Jun 30 2017	NAVB	NAVIDEA BIOPHARMAC ...	Fiorino Anthony S.	Director	Option Exercise	A	0.75	50,000	37,500	50,000
Jun 30 2017	NAVB	NAVIDEA BIOPHARMAC ...	Fiorino Anthony S.	Director	Grant	A	0.00	50,000	50	78,000	28 K to 78 K (+178.57 %)
May 31 2017	NAVB	NAVIDEA BIOPHARMAC ...	Latkin Jed	COO and CFO	Buy	P	0.44	7,600	3,317	50,159	42.6 K to 50.2 K (+17.86 %)
May 23 2017	NAVB	NAVIDEA BIOPHARMAC ...	Latkin Jed	COO and CFO	Buy	P	0.45	11,200	5,039	42,559	31.4 K to 42.6 K (+35.72 %)
May 23 2017	NAVB	NAVIDEA BIOPHARMAC ...	Latkin Jed	COO and CFO	Buy	P	0.45	14,159	6,387	31,359	17.2 K to 31.4 K (+82.32 %)
May 16 2017	NAVB	NAVIDEA BIOPHARMAC ...	GOLDBERG MICHAEL M	President & CEO	Grant	A	0.46	106,021	48,759	5,921,023	5.8 M to 5.9 M (+1.82 %)
May 05 2017	NAVB	NAVIDEA BIOPHARMAC ...	Latkin Jed	COO and CFO	Option Exercise	A	0.00	1,000,000	0	1,065,000
Feb 09 2017	NAVB	NAVIDEA BIOPHARMAC ...	Regan William J.	SVP & Chief Complia ...	Grant	A	0.52	79,155	41,161	116,962	37.8 K to 117 K (+209.37 %)
Feb 09 2017	NAVB	NAVIDEA BIOPHARMAC ...	Klima Thomas J	SVP & Chief Commerc ...	Grant	A	0.52	50,885	26,460	51,935	1.1 K to 51.9 K (+4,846.19 %)
Feb 09 2017	NAVB	NAVIDEA BIOPHARMAC ...	Cope Frederick O	SVP & Chief Scienti ...	Grant	A	0.52	88,378	45,957	180,593	92.2 K to 180.6 K (+95.84 %)
Jan 19 2017	NAVB	NAVIDEA BIOPHARMAC ...	GOLDBERG MICHAEL M	President & CEO	Option Exercise	X	0.01	5,411,850	54,119	0
Jan 19 2017	NAVB	NAVIDEA BIOPHARMAC ...	GOLDBERG MICHAEL M	President & CEO	Buy	X	0.01	5,411,850	54,119	5,815,002	403.2 K to 5.8 M (+1,342.38 %)
Jan 11 2017	NAVB	NAVIDEA BIOPHARMAC ...	Greene Mark I	Director	Grant	A	0.64	16,406	10,500	57,244	40.8 K to 57.2 K (+40.17 %)
Nov 01 2016	NAVB	NAVIDEA BIOPHARMAC ...	Latkin Jed	Interim COO	Option Exercise	A	1.00	20,000	20,000	20,000
Oct 19 2016	NAVB	NAVIDEA BIOPHARMAC ...	GOLDBERG MICHAEL M	President & CEO	Option Exercise	J	0.01	5,411,850	54,119	5,411,850
Oct 18 2016	NAVB	NAVIDEA BIOPHARMAC ...	Greene Mark I	Director	Grant	A	0.87	11,413	9,929	40,838	29.4 K to 40.8 K (+38.79 %)
Jul 07 2016	NAVB	NAVIDEA BIOPHARMAC ...	GOLDBERG MICHAEL M	Director	Grant	A	0.50	43,580	21,790	403,152	359.6 K to 403.2 K (+12.12 %)
Jul 07 2016	NAVB	NAVIDEA BIOPHARMAC ...	RICE YEHUDA MICHAEL	Director	Grant	A	0.00	28,000	0	28,000	0 to 28 K
Jul 07 2016	NAVB	NAVIDEA BIOPHARMAC ...	RICE YEHUDA MICHAEL	Director	Grant	A	0.00	28,000	0	28,000	0 to 28 K
Jul 07 2016	NAVB	NAVIDEA BIOPHARMAC ...	RICE YEHUDA MICHAEL	Director	Grant	A	0.00	28,000	0	28,000	0 to 28 K
Jul 07 2016	NAVB	NAVIDEA BIOPHARMAC ...	RICE YEHUDA MICHAEL	Director	Grant	A	0.00	28,000	0	28,000	0 to 28 K
May 03 2016	NAVB	NAVIDEA BIOPHARMAC ...	Troup Gordon A	Director	Grant	A	0.00	28,000	0	265,568	237.6 K to 265.6 K (+11.79 %)
Apr 29 2016	NAVB	NAVIDEA BIOPHARMAC ...	GOLDBERG MICHAEL M	Director	Grant	A	0.00	28,000	0	359,572	331.6 K to 359.6 K (+8.44 %)
Apr 29 2016	NAVB	NAVIDEA BIOPHARMAC ...	Greene Mark I	Director	Grant	A	1.37	1,425	1,952	29,425	28 K to 29.4 K (+5.09 %)
Apr 29 2016	NAVB	NAVIDEA BIOPHARMAC ...	Greene Mark I	Director	Grant	A	0.00	28,000	0	28,000	0 to 28 K
Apr 29 2016	NAVB	NAVIDEA BIOPHARMAC ...	Fiorino Anthony S.	Director	Grant	A	0.00	28,000	0	28,000	0 to 28 K
Apr 29 2016	NAVB	NAVIDEA BIOPHARMAC ...	Rowinsky Eric K	Director	Grant	A	0.00	28,000	0	224,446	196.4 K to 224.4 K (+14.25 %)
Apr 29 2016	NAVB	NAVIDEA BIOPHARMAC ...	Rowinsky Eric K	Director	Grant	A	1.14	10,726	12,228	196,446	185.7 K to 196.4 K (+5.78 %)
Feb 29 2016	NAVB	NAVIDEA BIOPHARMAC ...	LARSON BRENT L	EVP, CFO, Treas & S ...	Option Exercise	A	0.98	54,501	53,411	54,501
Feb 29 2016	NAVB	NAVIDEA BIOPHARMAC ...	Cope Frederick O	SVP & Chief Scienti ...	Option Exercise	A	0.98	58,510	57,340	58,510
Feb 29 2016	NAVB	NAVIDEA BIOPHARMAC ...	Regan William J.	SVP-Global Regulato ...	Option Exercise	A	1.50	25,000	37,500	25,000
Feb 29 2016	NAVB	NAVIDEA BIOPHARMAC ...	Klima Thomas J	SVP & Chief Commerc ...	Option Exercise	A	0.98	56,598	55,466	56,598
Feb 29 2016	NAVB	NAVIDEA BIOPHARMAC ...	Regan William J.	SVP, Chief Complian ...	Option Exercise	A	0.98	52,405	51,357	52,405
Jan 08 2016	NAVB	NAVIDEA BIOPHARMAC ...	GUETH ANTON	Director	Grant	A	1.22	16,918	20,640	38,918	22 K to 38.9 K (+76.90 %)
Dec 03 2015	NAVB	NAVIDEA BIOPHARMAC ...	LARSON BRENT L	EVP, CFO, Treas & S ...	Sell	S	1.50	12,500	18,750	222,237	234.7 K to 222.2 K (-5.33 %)
Nov 04 2015	NAVB	NAVIDEA BIOPHARMAC ...	LARSON BRENT L	EVP, CFO, Treas & S ...	Sell	S	1.98	12,500	24,750	234,737	247.2 K to 234.7 K (-5.06 %)
Oct 05 2015	NAVB	NAVIDEA BIOPHARMAC ...	LARSON BRENT L	EVP, CFO, Treas & S ...	Sell	S	2.27	12,500	28,375	247,237	259.7 K to 247.2 K (-4.81 %)
Sep 02 2015	NAVB	NAVIDEA BIOPHARMAC ...	LARSON BRENT L	EVP, CFO, Treas and ...	Sell	S	1.88	12,500	23,516	259,737	272.2 K to 259.7 K (-4.59 %)
Aug 05 2015	NAVB	NAVIDEA BIOPHARMAC ...	LARSON BRENT L	EVP, CFO, Treas and ...	Sell	S	1.71	12,500	21,330	272,237	284.7 K to 272.2 K (-4.39 %)
Aug 03 2015	NAVB	NAVIDEA BIOPHARMAC ...	FORD BRENDAN A	Director	Grant	A	1.61	9,317	15,000	239,950	230.6 K to 240 K (+4.04 %)
Jul 28 2015	NAVB	NAVIDEA BIOPHARMAC ...	Troup Gordon A	Director	Grant	A	1.61	10,559	17,000	232,314	221.8 K to 232.3 K (+4.76 %)
Jul 21 2015	NAVB	NAVIDEA BIOPHARMAC ...	DRAKE PETER F	Director	Sell	D	0.01	22,000	220	77,829	99.8 K to 77.8 K (-22.04 %)
Jul 21 2015	NAVB	NAVIDEA BIOPHARMAC ...	KARSEN PERRY A	Director	Sell	D	0.01	22,000	220	37,528	59.5 K to 37.5 K (-36.96 %)
Jul 06 2015	NAVB	NAVIDEA BIOPHARMAC ...	GUETH ANTON	Director	Grant	A	0.00	22,000	22	22,000	0 to 22 K
Jul 02 2015	NAVB	NAVIDEA BIOPHARMAC ...	LARSON BRENT L	EVP, CFO, Treas and ...	Sell	S	1.61	12,500	20,134	284,737	297.2 K to 284.7 K (-4.21 %)
Jun 02 2015	NAVB	NAVIDEA BIOPHARMAC ...	LARSON BRENT L	EVP, CFO, Treas and ...	Sell	S	1.24	12,500	15,538	297,237	309.7 K to 297.2 K (-4.04 %)
Jun 01 2015	NAVB	NAVIDEA BIOPHARMAC ...	Troup Gordon A	Director	Buy	P	1.31	10,000	13,098	221,715	211.7 K to 221.7 K (+4.72 %)
May 26 2015	NAVB	NAVIDEA BIOPHARMAC ...	FORD BRENDAN A	Director	Grant	A	1.31	20,000	26,226	230,633	210.6 K to 230.6 K (+9.50 %)
May 05 2015	NAVB	NAVIDEA BIOPHARMAC ...	LARSON BRENT L	EVP, CFO, Treas and ...	Sell	S	1.33	12,500	16,625	309,737	322.2 K to 309.7 K (-3.88 %)
Apr 03 2015	NAVB	NAVIDEA BIOPHARMAC ...	LARSON BRENT L	EVP, CFO, Treas and ...	Sell	S	1.58	20,000	31,550	322,237	342.2 K to 322.2 K (-5.84 %)
Mar 30 2015	NAVB	NAVIDEA BIOPHARMAC ...	LARSON BRENT L	EVP, CFO, Treas and ...	Option Exercise	A	1.65	151,000	249,150	151,000
Mar 30 2015	NAVB	NAVIDEA BIOPHARMAC ...	Regan William J.	SVP Global Reg Affa ...	Option Exercise	A	1.65	165,000	272,250	165,000
Mar 30 2015	NAVB	NAVIDEA BIOPHARMAC ...	Cope Frederick O	Senior VP and CSO	Option Exercise	A	1.65	162,000	267,300	162,000
Mar 30 2015	NAVB	NAVIDEA BIOPHARMAC ...	Tulip Thomas H.	Chief Bus. Officer	Payment of Exercise	F	1.65	7,645	12,614	70,773	78.4 K to 70.8 K (-9.75 %)
Mar 30 2015	NAVB	NAVIDEA BIOPHARMAC ...	Tulip Thomas H.	Chief Bus. Officer	Grant	A	0.00	20,000	0	78,418	58.4 K to 78.4 K (+34.24 %)
Mar 30 2015	NAVB	NAVIDEA BIOPHARMAC ...	Rowinsky Eric K	Director	Grant	A	0.00	22,000	0	185,720	163.7 K to 185.7 K (+13.44 %)
Mar 30 2015	NAVB	NAVIDEA BIOPHARMAC ...	Troup Gordon A	Director	Grant	A	0.00	22,000	0	211,755	189.8 K to 211.8 K (+11.59 %)
Mar 30 2015	NAVB	NAVIDEA BIOPHARMAC ...	DRAKE PETER F	Director	Grant	A	0.00	22,000	0	99,839	77.8 K to 99.8 K (+28.26 %)
Mar 30 2015	NAVB	NAVIDEA BIOPHARMAC ...	KARSEN PERRY A	Director	Grant	A	0.00	22,000	0	59,528	37.5 K to 59.5 K (+58.62 %)
Mar 30 2015	NAVB	NAVIDEA BIOPHARMAC ...	GOLDBERG MICHAEL M	Director	Grant	A	0.00	22,000	0	318,325	296.3 K to 318.3 K (+7.42 %)
Mar 30 2015	NAVB	NAVIDEA BIOPHARMAC ...	FORD BRENDAN A	Director	Grant	A	0.00	22,000	0	210,633	188.6 K to 210.6 K (+11.66 %)
Feb 09 2015	NAVB	NAVIDEA BIOPHARMAC ...	GOLDBERG MICHAEL M	Director	Grant	A	1.89	6,614	12,500	296,325	289.7 K to 296.3 K (+2.28 %)
Feb 09 2015	NAVB	NAVIDEA BIOPHARMAC ...	DRAKE PETER F	Director	Grant	A	1.89	7,606	14,375	77,829	70.2 K to 77.8 K (+10.83 %)
Feb 09 2015	NAVB	NAVIDEA BIOPHARMAC ...	FORD BRENDAN A	Director	Grant	A	1.89	7,937	15,001	188,633	180.7 K to 188.6 K (+4.39 %)
Feb 09 2015	NAVB	NAVIDEA BIOPHARMAC ...	KARSEN PERRY A	Director	Grant	A	1.89	7,276	13,752	37,528	30.3 K to 37.5 K (+24.05 %)
Feb 09 2015	NAVB	NAVIDEA BIOPHARMAC ...	Troup Gordon A	Director	Grant	A	1.89	7,406	13,997	189,755	182.3 K to 189.8 K (+4.06 %)
Dec 18 2014	NAVB	NAVIDEA BIOPHARMAC ...	Regan William J.	SVP-Global Regulato ...	Option Exercise	A	1.50	25,000	37,500	25,000
Dec 12 2014	NAVB	NAVIDEA BIOPHARMAC ...	LARSON BRENT L	EVP, CFO, Treas and ...	Option Exercise	M	0.39	50,000	19,500	0
Dec 12 2014	NAVB	NAVIDEA BIOPHARMAC ...	LARSON BRENT L	EVP, CFO, Treas and ...	Payment of Exercise	F	1.31	26,947	35,301	342,237	369.2 K to 342.2 K (-7.30 %)
Dec 12 2014	NAVB	NAVIDEA BIOPHARMAC ...	LARSON BRENT L	EVP, CFO, Treas and ...	Buy	M	0.39	50,000	19,500	369,184	319.2 K to 369.2 K (+15.66 %)
Dec 11 2014	NAVB	NAVIDEA BIOPHARMAC ...	Regan William J.	SVP-Global Regulato ...	Grant	A	0.00	20,000	0	30,000	10 K to 30 K (+200.00 %)
Nov 17 2014	NAVB	NAVIDEA BIOPHARMAC ...	GOLDBERG MICHAEL M	Director	Buy	P	1.12	28,359	31,890	289,711	261.4 K to 289.7 K (+10.85 %)

Page: 1 2 3 4 5 ... 5 next >